Radiation-induced fibrosis in rat lung: Modification by hydroxypiperquin phosphate
Mei Wang
Abstract
Mei Wang
Abstract
Purpose: To evaluate the HPQP as a modifier of radiation-induced pulmonary fibrosis in rats sacrificed 4 months and 6 months separately after a single dose of 0, 15, 20, 25 Gy60Co r rays to the right hemithorax. Methods: HPQP was administered by a stomach tube 2 times a week after irradiation at a regimen of 100mg/kg. Pulmonary fibrosis was evaluated by lung hydroxyproline( HP) content and histological observation( LM and EM). Results: The content of lung HP increased with increasing radiation dose. The differences between control group and 20,25 Gy group are significant P 0. 01). Cotreatment with HPQP significantly ameliorated this response (P 0. 01). The intensity of pulmonary pathological changes increased with increasing radiation dose also, and HPQP can lessen these changes greatly. Conclusions: HPQP may inhibit the progression of lung fibrosis and that the clinical application of HPQP is somehow evidenced by this study. This experiment also established an animal model of radiation-induced pulmonary fibrosis successfully.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Purpose: To evaluate the HPQP as a modifier of radiation-induced pulmonary fibrosis in rats sacrificed 4 months and 6 months separately after a single dose of 0, 15, 20, 25 Gy60Co r rays to the right hemithorax. Methods: HPQP was administered by a stomach tube 2 times a week after irradiation at a regimen of 100mg/kg. Pulmonary fibrosis was evaluated by lung hydroxyproline( HP) content and histological observation( LM and EM). Results: The content of lung HP increased with increasing radiation dose. The differences between control group and 20,25 Gy group are significant P 0. 01). Cotreatment with HPQP significantly ameliorated this response (P 0. 01). The intensity of pulmonary pathological changes increased with increasing radiation dose also, and HPQP can lessen these changes greatly. Conclusions: HPQP may inhibit the progression of lung fibrosis and that the clinical application of HPQP is somehow evidenced by this study. This experiment also established an animal model of radiation-induced pulmonary fibrosis successfully.
Key concepts: Hydroxyproline, Pulmonary fibrosis, Lung, Medicine, Fibrosis, Nuclear medicine, Pathological, Pulmonary toxicity